Our study revealed similar activity of miR-200b in BC by targeting Kindlin-2 in vitro; loss of adhesion and spreading, inhibition of focal adhesion formation, and inhibition of invadopodia and extracellular degradation. The gene discussed is FERMT2; the disease is breast cancer.